BIOMAT Database Logo BIOMAT Database Logo

Treatment of prosthetic tricuspid valve thrombosis with low-dose tissue plasminogen activator. 1990

M L Cohen, and B Barzilai, and F Gutierrez, and A S Jaffe, and P Eisenberg
Cardiovascular Division, Washington University School of Medicine, St. Louis, Mo. 63110.

UI MeSH Term Description Entries
D007262 Infusions, Intravenous The long-term (minutes to hours) administration of a fluid into the vein through venipuncture, either by letting the fluid flow by gravity or by pumping it. Drip Infusions,Intravenous Drip,Intravenous Infusions,Drip Infusion,Drip, Intravenous,Infusion, Drip,Infusion, Intravenous,Infusions, Drip,Intravenous Infusion
D010959 Tissue Plasminogen Activator A proteolytic enzyme in the serine protease family found in many tissues which converts PLASMINOGEN to FIBRINOLYSIN. It has fibrin-binding activity and is immunologically different from UROKINASE-TYPE PLASMINOGEN ACTIVATOR. The primary sequence, composed of 527 amino acids, is identical in both the naturally occurring and synthetic proteases. Alteplase,Plasminogen Activator, Tissue-Type,T-Plasminogen Activator,Tissue-Type Plasminogen Activator,Actilyse,Activase,Lysatec rt-PA,TTPA,Tisokinase,Tissue Activator D-44,Lysatec rt PA,Lysatec rtPA,Plasminogen Activator, Tissue,Plasminogen Activator, Tissue Type,T Plasminogen Activator,Tissue Activator D 44,Tissue Type Plasminogen Activator
D011475 Prosthesis Failure Malfunction of implantation shunts, valves, etc., and prosthesis loosening, migration, and breaking. Prosthesis Loosening,Prosthesis Durability,Prosthesis Migration,Prosthesis Survival,Durabilities, Prosthesis,Durability, Prosthesis,Failure, Prosthesis,Failures, Prosthesis,Loosening, Prosthesis,Loosenings, Prosthesis,Migration, Prosthesis,Migrations, Prosthesis,Prosthesis Durabilities,Prosthesis Failures,Prosthesis Loosenings,Prosthesis Migrations,Prosthesis Survivals,Survival, Prosthesis,Survivals, Prosthesis
D005260 Female Females
D006350 Heart Valve Prosthesis A device that substitutes for a heart valve. It may be composed of biological material (BIOPROSTHESIS) and/or synthetic material. Prosthesis, Heart Valve,Cardiac Valve Prosthesis,Cardiac Valve Prostheses,Heart Valve Prostheses,Prostheses, Cardiac Valve,Prostheses, Heart Valve,Prosthesis, Cardiac Valve,Valve Prostheses, Cardiac,Valve Prostheses, Heart,Valve Prosthesis, Cardiac,Valve Prosthesis, Heart
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D013927 Thrombosis Formation and development of a thrombus or blood clot in BLOOD VESSELS. Atherothrombosis,Thrombus,Blood Clot,Blood Clots,Thromboses
D014261 Tricuspid Valve The valve consisting of three cusps situated between the right atrium and right ventricle of the heart. Tricuspid Valves,Valve, Tricuspid,Valves, Tricuspid

Related Publications

M L Cohen, and B Barzilai, and F Gutierrez, and A S Jaffe, and P Eisenberg
Treatment of prosthetic tricuspid valve thrombosis with recombinant tissue-type plasminogen activator.
August 1987, European heart journal,
M L Cohen, and B Barzilai, and F Gutierrez, and A S Jaffe, and P Eisenberg
Successful treatment of prosthetic tricuspid valve thrombosis with short-course recombinant tissue-type plasminogen activator.
October 1990, American heart journal,
M L Cohen, and B Barzilai, and F Gutierrez, and A S Jaffe, and P Eisenberg
Thrombolysis of prosthetic tricuspid valve thrombosis with human recombinant tissue plasminogen activator in an adolescent.
January 2000, Pediatric cardiology,
M L Cohen, and B Barzilai, and F Gutierrez, and A S Jaffe, and P Eisenberg
Mechanical Tricuspid Valve Thrombosis Successfully Treated With Tissue Plasminogen Activator.
February 2024, JACC. Case reports,
M L Cohen, and B Barzilai, and F Gutierrez, and A S Jaffe, and P Eisenberg
Low-dose intravenous tissue-type plasminogen activator for prosthetic valve thrombosis is better than standard dose streptokinase.
September 2015, Revista portuguesa de cardiologia : orgao oficial da Sociedade Portuguesa de Cardiologia = Portuguese journal of cardiology : an official journal of the Portuguese Society of Cardiology,
M L Cohen, and B Barzilai, and F Gutierrez, and A S Jaffe, and P Eisenberg
Recombinant tissue plasminogen activator for prosthetic mitral-valve thrombosis.
July 1995, The New England journal of medicine,
M L Cohen, and B Barzilai, and F Gutierrez, and A S Jaffe, and P Eisenberg
A serial fluoroscopy-guided thrombolytic therapy of a mechanical tricuspid prosthetic valve thrombosis with low-dose and ultra-slow infusion of tissue-type plasminogen activator.
July 2014, Turk Kardiyoloji Dernegi arsivi : Turk Kardiyoloji Derneginin yayin organidir,
M L Cohen, and B Barzilai, and F Gutierrez, and A S Jaffe, and P Eisenberg
Intra-atrial tissue plasminogen activator infusion for prosthetic valve thrombosis.
January 2006, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions,
M L Cohen, and B Barzilai, and F Gutierrez, and A S Jaffe, and P Eisenberg
Mechanical Prosthetic Aortic Valve Thrombosis Treated with Low-dose Ultra Slow Infusion of Tissue-type Plasminogen Activator during Pregnancy.
March 2021, Journal of the College of Physicians and Surgeons--Pakistan : JCPSP,
M L Cohen, and B Barzilai, and F Gutierrez, and A S Jaffe, and P Eisenberg
Thrombolytic therapy for the treatment of prosthetic heart valve thrombosis in pregnancy with low-dose, slow infusion of tissue-type plasminogen activator.
July 2013, Circulation,
Copied contents to your clipboard!